Artigo Acesso aberto Revisado por pares

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

2019; National Comprehensive Cancer; Volume: 17; Issue: 12 Linguagem: Inglês

10.6004/jnccn.2019.0058

ISSN

1540-1413

Autores

Timothy D. Gilligan, Daniel W. Lin, Rahul Aggarwal, David D. Chism, Nicholas G. Cost, Ithaar Derweesh, Hamid Emamekhoo, Darren R. Feldman, Daniel M. Geynisman, Steven Hancock, Chad A. LaGrange, Ellis Levine, Thomas A. Longo, Will Lowrance, Bradley A. McGregor, Paul Monk, Joel Picus, Phillip M. Pierorazio, Soroush Rais‐Bahrami, Philip J. Saylor, Kanishka Sircar, David C. Smith, Katherine S. Tzou, Daniel A. Vaena, David J. Vaughn, Kosj Yamoah, Jonathan Yamzon, Alyse Johnson-Chilla, Jennifer Keller, Lenora A. Pluchino,

Tópico(s)

Sexual Differentiation and Disorders

Resumo

Testicular cancer is relatively uncommon and accounts for 50% of patients dying within 1 year of diagnosis. This selection from the NCCN Guidelines for Testicular Cancer focuses on recommendations for the management of adult patients with nonseminomatous GCTs.

Referência(s)